The article is not paywalled, but it's close: When I opened it in my incognito tab, it required that I set up a free Washington Post account where they'd send me spam to encourage me to join. Try this: Gilbert2.pdf. I printed out a .pdf of the same article.
The approaches used in the trials are not set in stone. Nor is the advice given by the FDA approved instructions as to dose to be applied religiously. I'm not sure that our actual approach is that different.
I use a quite unconventional dosing schedule. For most folks, it's overly complicated. I use an Excel sheet I found on Peppys that calculates how much mazdutide I have in the body. That figure is on the right. The figure on the left is how much I inject each day. As you can see, I ignore the...
If you read jellybelly54's post, he (or she) suggests that he followed the links from Alice's official vendor page. "So I thought this would be a good place to order my first order of peptides. Clicked on the links underneath the vendor. Took me to the discord page. Started a communication with...
Reta is fine but it creates problems with some people. Both semaglutide and tirzepatide created problems for some folks too. I personally use mazdutide. I'm not going to tell you whether it works for me or not because I started just a few weeks ago.
I am definitely not a fan of Donald Trump. However, this looks quite good so far, with the government pressuring two big drug companies to lower prices with assurances, I suspect, that far more people will be using the drugs. The drug companies still make large amounts of money -- as they...
Gilbert (Nov. 7, 2025). What you need to know about Medicare coverage for weight-loss drugs - Experts call President Donald Trump’s deal with drug companies a breakthrough, but details of how it will work are still emerging. Washington Post, paywall-free link: https://wapo.st/3WGwP87
Considering my success
I also see little reason to stop. I was unable to lose much weight without these drugs and even the weight I lost I was unable to keep off.
See also Hsia, et al (poster presentation, Obesity Week 2025). Eloralintide Phase 2 Study in Adult Participants With Overweight or Obesity - Design and Study Population...
In this 48 week study, mazdutide was given in different dosages. The study lasted 48 weeks. People who took 16 milligrams of mazdutide lost slightly over twice as much weight as those taking only six milligrams. Granted the people taking six milligrams actually spent the majority of their time...
She is a legitimate vendor. By that, I mean she has fulfilled purchases before. I do note that she promises to reship stuff if you have customs problems. I don't actually understand her message. Ask for clarification. But I wouldn't send any additional money to her other than for a new order...
@ZippityDooDah Maybe it's time to create a new category for eloralintide. It's an amylin-based weight loss drug.
Right now, most weight loss drugs are what are referred to as GLP-1 drugs, including drugs that only work on the GLP-1 system and drugs that also work on the glucagon and/or GIP...
I had never considered that something like this would help folks lose weight.
Singh, et al. (2025). Duodenal Mucosal Resurfacing Stabilizes Weight Loss After Glucagon-Like Peptide 1
Receptor Agonist Withdrawal. Poster at Obesity Week 2025...
The farther one deviates from the conditions in a study, the less likely the results in the study will apply to that person. I agree that individual outcomes different from group outcomes. So are group outcomes irrelevant? Not at all. If a drug was tested in a large group and in general...
glp1forum.com uses cookies and other similar functionality to help us personalize content, tailor your experience and to keep you logged in if you are a registered member.
By continuing to use this site, you are consenting to our use of cookies.